Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


04.09.2017

1 Exp Brain Res
1 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
3 J Neurosci
6 Mov Disord
1 Nat Neurosci
1 Nature
2 Neurochem Res
3 Neurosci Lett
1 Neuroscience
4 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Exp Brain Res

  1. GILLIES MJ, Hyam JA, Weiss AR, Antoniades CA, et al
    The Cognitive Role of the Globus Pallidus interna; Insights from Disease States.
    Exp Brain Res. 2017;235:1455-1465.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  2. MASILAMONI GJ, Smith Y
    Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.
    J Neural Transm (Vienna). 2017 Aug 31. doi: 10.1007/s00702-017-1774.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  3. SUZUKI K, Okuma Y, Uchiyama T, Miyamoto M, et al
    Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    J Neurol Neurosurg Psychiatry. 2017 Aug 28. pii: jnnp-2017-316136.
    PubMed     Text format     Abstract available


    J Neurosci

  4. SHAROTT A, Vinciati F, Nakamura KC, Magill PJ, et al
    A population of indirect pathway striatal projection neurons is selectively entrained to parkinsonian beta oscillations.
    J Neurosci. 2017 Aug 28. pii: 0658-17. doi: 10.1523/JNEUROSCI.0658-17.2017.
    PubMed     Text format     Abstract available

  5. TAGUCHI YV, Liu J, Ruan J, Pacheco J, et al
    Glucosylsphingosine promotes alpha-synuclein pathology in mutant GBA-associated Parkinson's disease.
    J Neurosci. 2017 Aug 28. pii: 1525-17. doi: 10.1523/JNEUROSCI.1525-17.2017.
    PubMed     Text format     Abstract available

  6. KORECKA JA, Moloney EB, Eggers R, Hobo B, et al
    Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's disease.
    J Neurosci. 2017 Aug 21. pii: 0084-17. doi: 10.1523/JNEUROSCI.0084-17.2017.
    PubMed     Text format     Abstract available


    Mov Disord

  7. BORGHAMMER P
    How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology.
    Mov Disord. 2017 Aug 26. doi: 10.1002/mds.27138.
    PubMed     Text format     Abstract available

  8. PARNETTI L, Paciotti S, Eusebi P, Dardis A, et al
    Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in parkinson's disease patients.
    Mov Disord. 2017 Aug 26. doi: 10.1002/mds.27136.
    PubMed     Text format     Abstract available

  9. TURCANO P, Mielke MM, Josephs KA, Bower JH, et al
    Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.
    Mov Disord. 2017 Aug 26. doi: 10.1002/mds.27125.
    PubMed     Text format     Abstract available

  10. HEINTZ-BUSCHART A, Pandey U, Wicke T, Sixel-Doring F, et al
    The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Mov Disord. 2017 Aug 26. doi: 10.1002/mds.27105.
    PubMed     Text format     Abstract available

  11. TREZZI JP, Galozzi S, Jaeger C, Barkovits K, et al
    Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.
    Mov Disord. 2017 Aug 26. doi: 10.1002/mds.27132.
    PubMed     Text format     Abstract available

  12. BRAKEDAL B, Flones I, Reiter SF, Torkildsen O, et al
    Glitazone use associated with reduced risk of Parkinson's disease.
    Mov Disord. 2017 Sep 1. doi: 10.1002/mds.27128.
    PubMed     Text format     Abstract available


    Nat Neurosci

  13. LOGAN T, Bendor J, Toupin C, Thorn K, et al
    alpha-Synuclein promotes dilation of the exocytotic fusion pore.
    Nat Neurosci. 2017;20:681-689.
    PubMed     Text format     Abstract available


    Nature

  14. KIKUCHI T, Morizane A, Doi D, Magotani H, et al
    Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
    Nature. 2017;548:592-596.
    PubMed     Text format     Abstract available


    Neurochem Res

  15. ZHAO Z, Wang J, Wang L, Yao X, et al
    Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson's Disease via Activation of TRPV1.
    Neurochem Res. 2017 Aug 31. doi: 10.1007/s11064-017-2388.
    PubMed     Text format     Abstract available

  16. LIMA FAV, Joventino IP, Joventino FP, de Almeida AC, et al
    Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.
    Neurochem Res. 2017 Aug 31. doi: 10.1007/s11064-017-2379.
    PubMed     Text format     Abstract available


    Neurosci Lett

  17. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Text format     Abstract available

  18. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Text format     Abstract available

  19. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Text format     Abstract available


    Neuroscience

  20. SONIA OD, Hector ES, Greger O, Sara AB, et al
    An altered blood-brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson's disease.
    Neuroscience. 2017 Aug 22. pii: S0306-4522(17)30589.
    PubMed     Text format     Abstract available


    PLoS One

  21. POKRZYWA M, Pawelek K, Kucia WE, Sarbak S, et al
    Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease.
    PLoS One. 2017;12:e0184117.
    PubMed     Text format     Abstract available

  22. LI T, Li W, Yang Y, Zhang W, et al
    Classification of brain disease in magnetic resonance images using two-stage local feature fusion.
    PLoS One. 2017;12:e0171749.
    PubMed     Text format     Abstract available

  23. RODRIGUEZ-MARTIN D, Sama A, Perez-Lopez C, Catala A, et al
    Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer.
    PLoS One. 2017;12:e0171764.
    PubMed     Text format     Abstract available

  24. PEPPOLONI L, Lawrence EL, Ruffaldi E, Valero-Cuevas FJ, et al
    Characterization of the disruption of neural control strategies for dynamic fingertip forces from attractor reconstruction.
    PLoS One. 2017;12:e0172025.
    PubMed     Text format     Abstract available


    Science

  25. MITTAL S, Bjornevik K, Im DS, Flierl A, et al
    beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease.
    Science. 2017;357:891-898.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: